SHIRLEY, NY – Jul 3, 2019 – Creative Proteomics, a leading supplier in metabolomics services, has recently launched its fully-developed untargeted metabolomics services to researchers. The service ranges include four: serum untargeted metabolomics, urine untargeted metabolomics, cerebrospinal fluid untargeted metabolomics, plant untargeted metabolomics, which are based on some of the most powerful platforms and techniques in this field with unrivaled accuracy and sensitivity.
Discovery metabolomics plays an important role in drug development. The most challenging approach to metabolomics and biomarker discovery may lie in the complex interpretation of “differential features” and how to convert a list of such features into metabolite identification and contextualize in biology. Methods of untargeted metabolite profiling typically involve statistical processing of LC-MS data to generate a list of features that can be identified. This typically involves multiple injections of the sample to ensure that information about the features of interest can be collected.
“Creative Proteomics’ solutions for discovery and untargeted metabolomics focus on generating comprehensive datasets containing large amounts of information through unique and modern approaches. Repeated planning with comprehensive statistics, along with tools developed by our collaborators aimed at identifying metabolites of interest through simplification and deconvolution of the data,” stated by Creative Proteomics’ executive vice president.
Serum, urine, and human cerebrospinal fluid are important biomarkers in the human body. The serum helps to regulate the ionic composition and pH of the interstitial fluid, and has the function of keeping a stable body temperature and defense against toxins and pathogens. Urine is the preferred diagnostic biological fluid in recent years because of its sterility and easy access. Creative Proteomics supports untargeted metabolomics experiments with a comprehensive set of ultra-sensitive separation, characterization, identification and quantification systems that provide urine untargeted metabolomics and serum untargeted metabolomics services. The insight of scientists is doubled by performing biochemical pathway-driven target analysis on the same data set.
At present, brain injury, multiple sclerosis and Parkinson’s disease have become human health killers. The treatment of such central nervous system diseases is inseparable from the study of human cerebral spinal fluid. It is not easily accessible, but its relative metabolic simplicity along with potential importance for central nervous system diseases makes it particularly important in biomedical research and clinical chemistry. Creative proteomics provides a mature cerebrospinal fluid untargeted metabolomics service to help scientists conduct disease research.
“Creative Proteomics is a professional biotech company specializing in providing untargetedmetabolomics services. Based on years’ of experience and knowledge in the application of plant metabolites analysis, Creative Proteomics can provide a fast turnaround, clear concise written reports, and custom plant untargeted metabolomics service to help customers resolve your analytical and technical challenges,” said Dr. Johnson.
About Creative Proteomics
Creative Proteomics, as an experienced proteomics, metabolomics, glycomics, and bioinformatics services supplier, has been equipped with advanced technologies to meet the growing needs of researchers and scientists in proteomics and metabolomics related researches.
Company Name: Creative Proteomics
Contact Person: Dora West
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States